Showing results (141-150 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|October 18, 2023
Anti-cancer Effect of a Planar Catechin Analog through the Decrease in Mitochondrial Membrane PotentialHiromu Ito, Yoshimi Shoji, Ken-Ichiro Matsumoto, et al.ACS Medicinal Chemistry Letters|October 18, 2023
Discovery of Pyrrolo[2,3-c]pyridines as Potent and Reversible LSD1 InhibitorsCanhui Zheng, Rohan Kalyan Rej, Mi Wang, et al.ACS Medicinal Chemistry Letters|September 22, 2023
Novel Compounds as TEAD Inhibitors for Treating CancerRam W SabnisACS Medicinal Chemistry Letters|September 22, 2023
Discovery of Novel, Thienopyridine-Based Tyrosine Kinase Inhibitors Targeting Tumorigenic RON Splice VariantsHyun Ryu, Hyojin Kim, Inwon Park, et al.ACS Medicinal Chemistry Letters|September 22, 2023
A Comparison of Di- and Trinuclear Platinum Complexes Interacting with Glycosaminoglycans for Targeted ChemotherapySamantha J Katner, Eric P Ginsburg, James D Hampton, et al.ACS Medicinal Chemistry Letters|September 22, 2023
Dose-Response Activity-Based DNA-Encoded Library ScreeningPatrick R Fitzgerald, Wesley G Cochrane, Brian M PaegelACS Medicinal Chemistry Letters|September 22, 2023
Fused Imidazopyrazine-Based Tubulin Polymerization Inhibitors Inhibit Neuroblastoma Cell FunctionJoshua Thammathong, Kaylee B Chisam, Garrett E Tessmer, et al.ACS Medicinal Chemistry Letters|July 19, 2023
Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous LeukemiaRam W SabnisACS Medicinal Chemistry Letters|July 19, 2023
Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of AmidinoureasSamantha Ottavi, Kelin Li, Jackson G Cacioppo, et al.ACS Medicinal Chemistry Letters|July 19, 2023
Subhallucinogenic Concentrations of Substituted Phenethylamines as a Novel Therapeutic Approach for Inflammatory and Neurological DisordersRobert B KargboPageof 438